Clusters | SARS-CoV-2 gene | SR gene | Drug | Interaction types |
---|---|---|---|---|
Cluster A | S, E, M, N, ORF7a | C3 | Zinc chloride | Inhibitor, ligand |
C3 | Methyldopa | Unknown | ||
S, E, N, ORF3a | C1R | Zinc chloride | Modulator | |
C1R | Methyldopa | Unknown | ||
S, E, N, ORF3a | C1S | Zinc chloride | Modulator | |
C1S | Methyldopa | Unknown | ||
S, E, M, N, ORF3a | CFB | Methyldopa | Unknown | |
Cluster B | S, E, M | PSMB3 | Bortezomib | Inhibitor |
PSMB3 | Carfilzomib | Inhibitor | ||
PSMB3 | Ixazomib citrate | Inhibitor | ||
S, E, N, ORF1ab, ORF3a | PSMC5 | Carfilzomib | Inhibitor | |
PSMC5 | Bortezomib | Inhibitor | ||
PSMC5 | Ixazomib citrate | Inhibitor | ||
M, ORF1ab, ORF7a, ORF8 | PSMC3 | Carfilzomib | Inhibitor | |
PSMC3 | Bortezomib | Inhibitor | ||
PSMC3 | Ixazomib citrate | Inhibitor |